PATENT CLAIM ANALYSIS

Application Number: 15765317
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["536", "024500"]

Abstract:
The present disclosure provides methods of treating a human having a disease or disorder that would benefit from increasing platelet counts. The method involves inhibiting the enzyme activity of biliverdin IXβ reductase (BLVRB) activity or inhibiting the expression of BLVRB gene.

Claim (Index 7):
The method of  claim 14 , wherein the increased breakdown of platelets is caused by one of: pregnancy, autoimmune disease, and medications.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 91.0
- Lexical Diversity: 1.28571
- Patent Class: 536.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14515619', '14138008', '14534394', '14650685', '13881587']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6077915780975293
- 35 USC 102 Novelty (BERT): 0.4941126173287581
- Combined Prediction Score: 0.5964236820206521
- Mean Citation Score: 186.45257
- Max Citation Score: 200.9485
- Similarity Product: 129.15838374644517

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test